This is a translation of the Swedish press release published 2022-09-01
Neola Medical AB (publ) announces that PhD MD Tetiana Kovtiukh has been recruited as Clinical Manager, starting her full-time position in September 2022. Tetiana will ensure clinical compatibility in product development and regulatory processes and build a clinical network for the company. Tetiana Kovtiukh is a neonatologist and worked most recently at Taras Shevchenko National University of Kyiv, Ukraine, teaching international students at the department for clinical medicine, and have previously also worked as a medical advisor at AbbVie and Teva.
“Since we are in the process for regulatory approvals in the EU and the U.S., and are preparing for market launch, I am happy that we have strengthened the team with an experienced doctor in neonatology, who also have experience from the industry. It is rare to have the combined experience from both the clinical and the industry side, and this will be highly valuable for our company.”, says Hanna Sjöström, CEO at Neola Medical.
The full translation of the Swedish press release: Translated press communication
The official press release (in Swedish): Pressmeddelande